IMDX
Insight Molecular Diagnostics Inc.NASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$103.26M
P/E Ratio
—
EPS
$-1.65
Beta
1.53
52W High
$8.51
52W Low
$2.33
50-Day MA
$5.33
200-Day MA
$4.67
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Insight Molecular Diagnostics Inc.
OncoCyte Corporation is a precision diagnostics company in the United States and internationally. The company is headquartered in Irvine, California.
Fundamentals
| Revenue (TTM) | $4.05M |
| Gross Profit (TTM) | $2.31M |
| EBITDA | $-28.30M |
| Operating Margin | -874.00% |
| Return on Equity | -23603.00% |
| Return on Assets | -62.70% |
| Revenue/Share (TTM) | $0.13 |
| Book Value | $-1.10 |
| Price-to-Book | 196.27 |
| Price-to-Sales (TTM) | 25.46 |
| EV/Revenue | 27.83 |
| EV/EBITDA | -1.25 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -23.40% |
| Shares Outstanding | $32.17M |
| Float | $10.72M |
| % Insiders | 20.09% |
| % Institutions | 53.85% |
Analyst Ratings
Consensus ($8.33 target)
1
Strong Buy1
Buy2
HoldData last updated: 4/8/2026